Practice · Ophthalmic Surgery

High-volume ophthalmic intake — engineered around your OT throughput.

We build cataract-camp, refractive, retina and corneal-transplant funnels — measured in scheduled surgeries and OT throughput, not enquiry counts.

For Chiefs of Ophthalmology, Cataract Programme Heads and MDs of eye super-specialty hospitals and chains.

Request a Ophthalmology Pipeline Blueprint →Review case evidence

Premium IOL Mix

38%

of cataract cases post-engagement

OT Throughput

+2.4×

cases per surgeon per day

Refractive Volume

+152%

9-month cohort

Diabetic-Retina Screening

+218%

endocrinologist network

Procedure-level demand engineering

We target the procedures that move your P&L, not the ones that fill the OPD queue.

CATCHMENT TIER · PRICE RESTATEMENT

ARPU differs materially between Metro, Tier-2 and Tier-3 catchments. Switch tier to restate every procedure band against the payer mix and package ceilings we observe in that market — not a single all-India number.

Viewing Metro / Tier-1 · Representative catchments: Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune.

Phaco Cataract + Premium IOL

₹40K–1.4 L

Age-cohort screening → premium upsell

LASIK / SMILE / ICL

₹80K–1.8 L

Refractive lifestyle-lead funnel

Vitreo-Retinal Surgery

₹60K–2.4 L

Diabetic-retina referral pathway

Glaucoma Surgery

₹50K–1.6 L

Chronic-glaucoma progression funnel

Corneal Transplant (DMEK/DALK)

₹1.4 L–3.2 L

Long-cycle premium referral

Paediatric Ophthalmology

₹40K–1.2 L

Squint & amblyopia referral funnel

Methodology. Base bands reflect RDV's engagement dataset across 47 super-specialty hospitals, reconciled against CGHS/ECHS package rates, state-scheme ceilings (Ayushman Bharat PM-JAY, CMCHIS, YSR Aarogyasri) and empanelled TPA grids. Tier multipliers applied: Metro 1.00× · Tier-2 0.72× · Tier-3 0.55×. Actuals swing with payer mix, consultant-fee split and implant/consumable choice — the written Blueprint restates every band against your own HIS billing history before any spend is committed.

Clinical referral pathway

Intent → triage → consult → admission. Instrumented at every gate.

01 · Intent capture
Symptom, condition and referrer-based intent capture across catchment.
02 · Clinical triage
Specialty-trained nurse/coordinator triage with report upload before consult.
03 · Consultant handoff
Calendar-synced booking to the operating consultant with pre-read notes.
04 · Admission & OT slotting
CRM ↔ HIS tag: admission source, procedure code, OT date.

Case snapshot

2.4× OT throughput, 38% premium IOL mix.

A representative RDV engagement in the Ophthalmic Surgery practice line. Individual results vary by catchment, clinical capacity and payer mix.

Setting: Eye super-specialty chain, 4 units, Tier-1 metro
Duration: 12 months
Cohort: n = 12,400 qualified enquiries
Outcome: 2.4× OT throughput, 38% premium IOL mix

Figures engagement-verified against hospital HIS. No outcome guarantees implied; per NMC advertising guidelines.

Why Chiefs of Ophthalmology choose RDV

Trust is earned in the operating logic, not the pitch deck.

Throughput-aware pacing

Media pacing aligned to surgeon-day OT capacity. No queue overflow, no patient-experience decay.

Refractive candidacy honesty

Every refractive enquiry gets pre-screening. Unsuitable candidates are told, not sold — building the highest referral rate in the category.

Premium IOL clinical framing

Trifocal and toric IOL positioned by clinical benefit (dysphotopsia trade-offs disclosed), never as luxury upsell.

Diabetic-retina endocrine MOUs

Retina volume built through endocrinologist referral networks, not consumer ads for a silent-symptom disease.

From an engagement

"The candidacy-honesty protocol counter-intuitively increased LASIK volume. Trust turned into referrals — the CAC dropped by half in six months."

— Chief of Refractive Surgery · Multi-unit eye chain

Attribution anonymised per client confidentiality; engagement code verifiable in the founder-led review.

Talk directly to the founding partner who ran this engagement.

Request a Ophthalmology Blueprint →

48-hour founder-led review. Fixed-scope. No lock-in.

Clinical authority

Content your clinicians will co-sign.

Ophthalmic surgeon IOL-selection framework
Refractive candidacy transparency library
Diabetic-retinopathy screening co-management

Compliance posture

Every asset, every claim, medically reviewed.

NMC norms — refractive-outcome caveats mandatory
Age-appropriate screening claims backed by internal audit
Corneal-transplant messaging aligned to Eye Bank Association of India norms

Catchment note: Metropolitan cataract-camp engineering; refractive corridors targeting IT & aviation demographics.

The 21-day diagnostic

What the fixed-scope engagement actually contains — for Ophthalmology.

No mystery, no scope creep. Each week is instrumented and delivered against a checklist your MD and Chief signs.

Week 1
OT throughput audit; per-surgeon-per-day baseline.
Week 2
Age-cohort catchment + endocrinologist referrer mapping.
Week 3
Procedure-mix economics; premium-IOL uplift model.
Week 4
Founder-led blueprint with Chief of Ophthalmology.

Where we compound

The unfair edge — for Ophthalmology specifically.

Surgeon-day throughput modelling — rare precision in category
Refractive candidacy-honesty framework compounds referral volume
Endocrine-MOU network for diabetic-retina screening

Practice guarantees

What we commit to in writing.

Fixed-scope diagnostic — no retainer, no annual lock-in
HIS-verified attribution — every claimed admission traceable to source
No media markup — you see raw platform invoices at cost
Founder-led — the partner who scopes the engagement does the work

Objections we hear

The three questions MDs ask before signing.

We keep our answers on the record. If yours isn't here, ask it in the qualification form — the founding partner replies personally within 48 hours.

Cataract is commoditised — everyone runs camps.

Which is why premium-IOL mix is the real economic lever. We shift the funnel from volume-only to mix-optimised — different metric, different margin.

LASIK marketing is aggressive everywhere.

And churns on trust. Our candidacy-honesty protocol converts less at first touch but generates a compounding referral engine within two quarters.

Retina isn't a marketable specialty.

Not to consumers. It's an endocrinologist-network specialty. That's where our engineering focuses.

FAQ

The questions Chiefs of Ophthalmology ask us first.

If yours isn't here, put it in the qualification form — our founding partner will answer it in the 48-hour review.

Can you increase premium IOL mix ethically?+

Yes — by educating patients on lifestyle needs and disclosing trade-offs (glare, halos, near-vision compromises). Informed choice converts better and complains less.

How do you handle LASIK-unsuitable enquiries?+

They receive an alternative-options education pathway (ICL, PRK) or a clear 'not-suitable' recommendation. Non-conversion protects your brand.

Do you run cataract camps?+

Yes, but as governance-aligned screening events with pre-op assessment and consent workflows — never as high-pressure surgical-conversion venues.

Next step